American Family Children's Hospital
Peiman Hematti, MD close
Peiman Hematti, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Peiman Hematti, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Peiman Hematti joined the Section of Hematology/Bone Marrow Transplantation at the University of Wisconsin-Madison in July 2004 as an Assistant Professor in the Department of Medicine. Dr. Hematti has completed a combined Internal Medicine/Pediatrics residency at the Cleveland Clinic Foundation and then Hematology fellowship at the National Heart, Lung and Blood Institute at the National Institutes of Health. His clinical interests are in inpatient care of hematopoietic stem cell transplant patients. He is the director of the clinical hematopoietic cell processing laboratory, and in that capacity oversees all the peripheral blood stem cell collections from the patients and processing of their products.



UW Health Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital (primary)
Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Medicine

Department of Pediatrics

Professional Certifications and Education

Board Certification Internal Medicine
Fellowship National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
Residency Cleveland Clinic Foundation, OH
Internship Cleveland Clinic Foundation, OH
Medical School Tehran University of Medical Sciences, Iran, 1990

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.


Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Programs & Conditions


Dr. Hematti runs an active basic research lab with the goal of developing methods for ex vivo generation and expansion of hematopoietic stem cells. His clinical research interest is in using novel mobilization agents for collection of peripheral blood stem cells.

PubMed Articles
Denu RA Nemcek S Bloom DD Goodrich AD Kim J Mosher DF Hematti P . Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable. Acta Haematol. 2016 May 18;136(2):85-97
[PubMed ID: 27188909]
Braun RK Koch JM Hacker TA Pegelow D Kim J Raval AN Schmuck EG Schwahn DJ Hei DJ Centanni JM Eldridge M Hematti P . Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion. Cytotherapy. 2016 Apr;18(4):536-45
[PubMed ID: 26971682]
Hematti P . Characterization of mesenchymal stromal cells: potency assay development. Transfusion. 2016 Apr;56(4):32S-5S
[PubMed ID: 27079322]
Anthias C Shaw BE Kiefer DM Liesveld JL Yared J Kamble RT D'Souza A Hematti P Seftel MD Norkin M DeFilipp Z Kasow KA Abidi MH Savani BN Shah NN Anderlini P Diaz MA Malone AK Halter JP Lazarus HM Logan BR Switzer GE Pulsipher MA Confer DL O'Donnell PV . Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. Biol Blood Marrow Transplant. 2016 Mar;22(3):520-7
[PubMed ID: 26597080]
Yu W Denu RA Krautkramer KA Grindle KM Yang DT Asimakopoulos F Hematti P Denu JM . Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. J Biol Chem. 2016 Feb 12;291(7):3268-79
[PubMed ID: 26631723]
Galipeau J Krampera M Barrett J Dazzi F Deans RJ DeBruijn J Dominici M Fibbe WE Gee AP Gimble JM Hematti P Koh MB LeBlanc K Martin I McNiece IK Mendicino M Oh S Ortiz L Phinney DG Planat V Shi Y Stroncek DF Viswanathan S Weiss DJ Sensebe L . International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2016 Feb;18(2):151-9
[PubMed ID: 26724220]
Hanson SE Kleinbeck KR Cantu D Kim J Bentz ML Faucher LD Kao WJ Hematti P . Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model. J Tissue Eng Regen Med. 2016 Feb;10(2):E90-E100
[PubMed ID: 23418160]
Shaw BE Logan BR Kiefer DM Chitphakdithai P Pedersen TL Abdel-Azim H Abidi MH Akpek G Diaz MA Artz AS Dandoy C Gajewski JL Hematti P Kamble RT Kasow KA Lazarus HM Liesveld JL Majhail NS O'Donnell PV Olsson RF Savani BN Schears RM Stroncek DF Switzer GE Williams EP Wingard JR Wirk BM Confer DL Pulsipher MA . Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. Biol Blood Marrow Transplant. 2015 Oct;21(10):1830-8
[PubMed ID: 26116089]
Schmuck EG Koch JM Hacker TA Hatt CR Tomkowiak MT Vigen KK Hendren N Leitzke C Zhao YQ Li Z Centanni JM Hei DJ Schwahn D Kim J Hematti P Raval AN . Intravenous Followed by X-ray Fused with MRI-Guided Transendocardial Mesenchymal Stem Cell Injection Improves Contractility Reserve in a Swine Model of Myocardial Infarction. J Cardiovasc Transl Res. 2015 Oct;8(7):438-48
[PubMed ID: 26374144]
Jensen JL Rakhmilevich A Heninger E Broman AT Hope C Phan F Miyamoto S Maroulakou I Callander N Hematti P Chesi M Bergsagel PL Sondel P Asimakopoulos F . Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma. Cancer Immunol Res. 2015 Aug;3(8):881-90
[PubMed ID: 25941352]
Gupta A Place M Goldstein S Sarkar D Zhou S Potamousis K Kim J Flanagan C Li Y Newton MA Callander NS Hematti P Bresnick EH Ma J Asimakopoulos F Schwartz DC . Single-molecule analysis reveals widespread structural variation in multiple myeloma. Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7689-94
[PubMed ID: 26056298]
Guerra AD Cantu DA Vecchi JT Rose WE Hematti P Kao WJ . Mesenchymal Stromal/Stem Cell and Minocycline-Loaded Hydrogels Inhibit the Growth of Staphylococcus aureus that Evades Immunomodulation of Blood-Derived Leukocytes. AAPS J. 2015 May;17(3):620-30
[PubMed ID: 25716147]
Arai S Arora M Wang T Spellman SR He W Couriel DR Urbano-Ispizua A Cutler CS Bacigalupo AA Battiwalla M Flowers ME Juckett MB Lee SJ Loren AW Klumpp TR Prockup SE Ringdén OT Savani BN Socié G Schultz KR Spitzer T Teshima T Bredeson CN Jacobsohn DA Hayashi RJ Drobyski WR Frangoul HA Akpek G Ho VT Lewis VA Gale RP Koreth J Chao NJ Aljurf MD Cooper BW Laughlin MJ Hsu JW Hematti P Verdonck LF Solh MM Norkin M Reddy V Martino R Gadalla S Goldberg JD McCarthy PL Pérez-Simón JA Khera N Lewis ID Atsuta Y Olsson RF Saber W Waller EK Blaise D Pidala JA Martin PJ Satwani P Bornhäuser M Inamoto Y Weisdorf DJ Horowitz MM Pavletic SZ . Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015 Feb;21(2):266-74
[PubMed ID: 25445023]
Bloom DD Centanni JM Bhatia N Emler CA Drier D Leverson GE McKenna DH Jr Gee AP Lindblad R Hei DJ Hematti P . A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. Cytotherapy. 2015 Feb;17(2):140-51
[PubMed ID: 25455739]
Hsu JW Wingard JR Logan BR Chitphakdithai P Akpek G Anderlini P Artz AS Bredeson C Goldstein S Hale G Hematti P Joshi S Kamble RT Lazarus HM O'Donnell PV Pulsipher MA Savani BN Schears RM Shaw BE Confer DL . Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. Biol Blood Marrow Transplant. 2015 Jan;21(1):165-71
[PubMed ID: 25316111]
Cuiffo BG Campagne A Bell GW Lembo A Orso F Lien EC Bhasin MK Raimo M Hanson SE Marusyk A El-Ashry D Hematti P Polyak K Mechta-Grigoriou F Mariani O Volinia S Vincent-Salomon A Taverna D Karnoub AE . MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell. 2014 Dec 4;15(6):762-74
[PubMed ID: 25515522]
Raval AN Schmuck EG Tefera G Leitzke C Ark CV Hei D Centanni JM de Silva R Koch J Chappell RG Hematti P . Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. Cytotherapy. 2014 Dec;16(12):1720-32
[PubMed ID: 25239491]
Callander N Markovina S Eickhoff J Hutson P Campbell T Hematti P Go R Hegeman R Longo W Williams E Asimakopoulos F Miyamoto S . Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. Cancer Chemother Pharmacol. 2014 Oct;74(4):875-82
[PubMed ID: 25168296]
Goodrich AD Varain NM Jeanblanc CM Colon DM Kim J Zanjani ED Hematti P . Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model. Cytotherapy. 2014 Sep;16(9):1280-93
[PubMed ID: 25108653]
Hanley PJ Mei Z Durett AG Cabreira-Hansen Mda G Klis M Li W Zhao Y Yang B Parsha K Mir O Vahidy F Bloom D Rice RB Hematti P Savitz SI Gee AP . Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. Cytotherapy. 2014 Aug;16(8):1048-58
[PubMed ID: 24726657]